Stay updated with breaking news from Shape Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Unlike the much-buzzed-about CRISPR-Cas9 gene-editing system, RNA editing doesn’t cause permanent changes to the genome, and could therefore have its own applications in treating genetic disorders.
New RNA editing technology may provide a simpler way to repair disease-causing mutations in RNA without compromising precision or efficiency.
New research led by bioengineers at the University of California San Diego could make it much simpler to repair disease-causing mutations in RNA without
Biotechs Lexeo Therapeutics and Shape Therapeutics gave the public its first look at the one-and-done gene therapies they're creating for Alzheimer's.
Besides Omicron, the industry will focus on RNA-based drugs, AI programs, gene therapy trials, financing deals, regulatory issues, and synthetic biology challenges.